United States Wiskott-Aldrich Syndrome Treatment Market by Application Wiskott-Aldrich Syndrome (WAS) is a rare X-linked recessive disorder characterized by immune deficiency, eczema, and thrombocytopenia. In the United States, the treatment market for Wiskott-Aldrich Syndrome is segmented primarily by application, focusing on therapeutic interventions aimed at managing the symptoms and improving […]
Recent News